calendar
16 catalysts · 5 filing · 4 phase 2 completion · 2 phase 3 initiation · 1 phase 1 2 completion · 1 phase 1 completion · 1 phase 0 trial completion
next 91 dayslessmore
MonWedFri
16 catalysts · 5 filing · 4 phase 2 completion · 2 phase 3 initiation · 1 phase 1 2 completion · 1 phase 1 completion · 1 phase 0 trial completion
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Asthenopia (Eye Strain), Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Therapy area: Ophthalmology. Indication: Blepharitis, Ptosis
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)
Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Branch Retinal Vein Occlusion, Diabetic Macular Edema, Macular Edema, Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)